UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance

Nature communications, 2021-06, Vol.12 (1), p.3904-3904, Article 3904

2021

Volltextzugriff (PDF)

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients

Clinical cancer research, 2018-09, Vol.24 (18), p.4482-4493

2018

Volltextzugriff (PDF)

Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells

Molecular & cellular proteomics, 2017-07, Vol.16 (7), p.1377-1392

2017

Volltextzugriff (PDF)

FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion

PloS one, 2013-09, Vol.8 (9), p.e74923-e74923

2013

Volltextzugriff (PDF)

Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status

Frontiers in oncology, 2022-08, Vol.12, p.954430-954430

2022

Volltextzugriff (PDF)

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker

PloS one, 2016-03, Vol.11 (3), p.e0151590-e0151590

2016

Volltextzugriff (PDF)

Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition

Frontiers in oncology, 2021-09, Vol.11, p.733700-733700

2021

Volltextzugriff (PDF)

Melanocortin 3 receptor activation with [D-Trp8]-γ-MSH suppresses inflammation in apolipoprotein E deficient mice

European journal of pharmacology, 2020-08, Vol.880, p.173186-173186, Article 173186

2020

Volltextzugriff (PDF)

ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

The Journal of pathology, 2020-02, Vol.250 (2), p.159-169

2020

Volltextzugriff (PDF)

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer

Science advances, 2022-02, Vol.8 (8), p.eabm1831-eabm1831

2022

Volltextzugriff (PDF)

Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells

European urology, 2019-10, Vol.76 (4), p.430-434

2019

Volltextzugriff (PDF)

PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples

Bioinformatics (Oxford, England), 2021-09, Vol.37 (18), p.2882-2888

2021

Volltextzugriff (PDF)

Transgenic Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons

Diabetes (New York, N.Y.), 2008-06, Vol.57 (6), p.1517-1525

2008

Volltextzugriff (PDF)

Agile workflow for interactive analysis of mass cytometry data

Bioinformatics, 2021-06, Vol.37 (9), p.1263-1268

2021

Volltextzugriff (PDF)

Abstract 875: Chemical biology approach to phenotypic intra-tumor heterogeneity in high-grade serous ovarian cancer

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.875-875

2018

Volltextzugriff (PDF)

qSNE: quadratic rate t-SNE optimizer with automatic parameter tuning for large datasets

Bioinformatics, 2020-12, Vol.36 (20), p.5086-5092

2020

Volltextzugriff (PDF)

Abstract A57: Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.A57-A57

2018

Volltextzugriff (PDF)

Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype

Molecular cancer therapeutics, 2022-07, Vol.21 (7), p.1236-1245

2022

Volltextzugriff (PDF)

A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer

Cancers, 2022-09, Vol.14 (17), p.4291

2022

Volltextzugriff (PDF)

The intracellular mobility of NPY and a putative mitochondrial form of NPY in neuronal cells

Neuroscience letters, 2009-01, Vol.450 (2), p.181-185

2009

Volltextzugriff (PDF)

Abstract A40: Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer

Clinical cancer research, 2020-07, Vol.26 (13_Supplement), p.A40-A40

2020

Volltextzugriff (PDF)

Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15), p.2987-2998

2015

Volltextzugriff (PDF)

Abstract 1428: Single-cell transcriptomics reveals differential DNA repair signatures after chemotherapy in high-grade serous ovarian cancer

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.1428-1428

2017

Volltextzugriff (PDF)

Abstract B40: High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment

Clinical cancer research, 2018-08, Vol.24 (15_Supplement), p.B40-B40

2018

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(47)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Clinical Cancer Research
(10)
Cancer Research
(6)
Bioinformatics
(4)
The Faseb Journal
(3)
Biochemical And Biophysical Research Communications
(2)
Diabetes
(2)
Frontiers In Oncology
(2)
Plos One
(2)
Acta Neuropsychiatrica
(1)
Annals Of Medicine
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance

A Functional Homologous Recombination Assay Predicts Primary Chemotherapy Response and Long-Term Survival in Ovarian Cancer Patients

Hyper-phosphorylation of Sequestosome-1 Distinguishes Resistance to Cisplatin in Patient Derived High Grade Serous Ovarian Cancer Cells

FHOD1, a formin upregulated in epithelial-mesenchymal transition, participates in cancer cell migration and invasion

Effects of Wee1 inhibitor adavosertib on patient-derived high-grade serous ovarian cancer cells are multiple and independent of homologous recombination status

REG4 Is Highly Expressed in Mucinous Ovarian Cancer: A Potential Novel Serum Biomarker

Targeting DNA Homologous Repair Proficiency With Concomitant Topoisomerase II and c-Abl Inhibition

Melanocortin 3 receptor activation with [D-Trp8]-γ-MSH suppresses inflammation in apolipoprotein E deficient mice

ALDH1A1‐related stemness in high‐grade serous ovarian cancer is a negative prognostic indicator but potentially targetable by EGFR/mTOR‐PI3K/aurora kinase inhibitors

Longitudinal single-cell RNA-seq analysis reveals stress-promoted chemoresistance in metastatic ovarian cancer

Personalized Drug Sensitivity Screening for Bladder Cancer Using Conditionally Reprogrammed Patient-derived Cells

A platform for efficient establishment and drug-response profiling of high-grade serous ovarian cancer organoids

PRISM: recovering cell-type-specific expression profiles from individual composite RNA-seq samples

Transgenic Mice Overexpressing Neuropeptide Y in Noradrenergic Neurons

Agile workflow for interactive analysis of mass cytometry data

Abstract 875: Chemical biology approach to phenotypic intra-tumor heterogeneity in high-grade serous ovarian cancer

qSNE: quadratic rate t-SNE optimizer with automatic parameter tuning for large datasets

Abstract A57: Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines

Ovarian Cancers with Low CIP2A Tumor Expression Constitute an APR-246-Sensitive Disease Subtype

A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer

The intracellular mobility of NPY and a putative mitochondrial form of NPY in neuronal cells

Abstract A40: Singling out tumor heterogeneity and chemoresistance in high-grade serous ovarian cancer

Identification of Prognostic Groups in High-Grade Serous Ovarian Cancer Treated with Platinum-Taxane Chemotherapy

Abstract 1428: Single-cell transcriptomics reveals differential DNA repair signatures after chemotherapy in high-grade serous ovarian cancer

Abstract B40: High-throughput screening of new potential targets for high-grade serous ovarian cancer treatment

Suchergebnisse filtern